Chione Ltd is 10% Owner at Karyopharm Therapeutics Inc. (KPTI). They have made 7 open-market trades across 2 companies since 2016, most recently 2023-06-14.
CIK 0001503802
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 71% | 71% | 100% |
| Avg Move | -5.7% | -13.2% | -17.2% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACRV | SELL | 2023-06-12 | 2023-06-14 | $12.29 | $72K | +5.4% | +0.0% | -11.1% |
| KPTI | SELL | 2018-08-27 | 2018-08-29 | $19.46 | $4.4M | -1.9% | -15.4% | -49.7% |
| KPTI | SELL | 2018-08-10 | 2018-08-14 | $18.50 | $13K | -0.9% | +2.9% | -41.5% |
| KPTI | SELL | 2016-06-07 | 2016-06-08 | $9.25 | $185K | -15.9% | -22.5% | -2.2% |
| KPTI | SELL | 2016-06-06 | 2016-06-08 | $9.24 | $370K | -15.9% | -22.5% | -2.2% |
| KPTI | SELL | 2016-06-06 | 2016-06-08 | $9.22 | $184K | -15.9% | -22.5% | -2.2% |
| KPTI | SELL | 2016-05-19 | 2016-05-23 | $8.54 | $802K | +5.1% | -12.7% | -11.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.